News

/News

The Grey Market Is…

  Keith Watts Abstract This is the first in a series discussing the unnecessary failure of major drug manufacturers to address legitimate patient-specific early access, also called “named patient” access, worldwide. US pharmaceutical manufacturers have a poor understanding of the gray market that channel supplying newly FDA approved medicines outside the US. This poor understanding [...]

By |2017-12-06T16:52:50+00:00December 6th, 2017|News|0 Comments

Partners in International Ethical Access: ABDEKs MultiVitamins

Atlanta, GA, (June 20, 2017): One-World Inc. (OWI) is proud to assist H2-Pharma in implementing ethical and regulatory compliant access to advanced products for healthcare professionals in countries prior to regulatory approval. H2-Pharma’s MultiVitamin ABDEKs are specifically formulated for individuals with malabsorption conditions, such as Cystic Fibrosis*, that have difficulty in absorbing fat-soluble vitamins. ABDEKs [...]

By |2018-01-10T17:05:34+00:00June 26th, 2017|News, Press Releases|0 Comments

Partners in Ethical Access–One-World and Forward Science™ Present SalivaMAX™

Atlanta, GA, (June 5, 2017)–  One-World Inc. (OWI) is proud to assist Forward Science™ in implementing ethical regulatory compliant access to advanced technologies for oral oncologists and other healthcare professionals in countries prior to regulatory approval. SalivaMAX™ has been commercially available in the United States since February 2016. SalivaMAX™  is a prescription strength rinse that is indicated [...]

By |2018-01-11T15:24:27+00:00June 6th, 2017|News, Press Releases|0 Comments

Have you seen the new Opdivo Commercial?

Keith Watts. December 2016   Bristol-Myers Squibb (BMY) has created a very compelling commercial with a strong message that goes something like this: “Ask your doctor about Opdivo for a chance at a longer life.”[1] This is very encouraging for anyone who has run out of treatment alternatives and is fortunate enough to live in [...]

By |2018-01-24T22:28:45+00:00December 15th, 2016|News|0 Comments

The Patient Cannot Afford to Wait for FDA Approved Medication

Keith Watts. July 2016 I have spent the overwhelming majority of my professional life in the pharmaceutical industry.  I have watched, and to some degree engaged in the pharmaceutical industry’s evolution over many years.  It is my view that most pharmaceutical manufacturers are good corporate citizens.  Most of these companies have a decent track [...]

By |2018-01-24T22:31:07+00:00September 27th, 2016|News|0 Comments